As of April 2024 BiondVax has a market cap of $4.96 Million. This makes BiondVax the world's 8241th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.96 M | 0% |
2023 | $4.96 M | -11.01% |
2022 | $5.58 M | -87.15% |
2021 | $43.41 M | 34.05% |
2020 | $32.39 M | -65.34% |
2019 | $93.44 M | 199.75% |
2018 | $31.17 M | -11.01% |
2017 | $35.03 M | 209.61% |
2016 | $11.31 M | -15.4% |
2015 | $13.37 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.53 B | 10,759.35% | ๐บ๐ธ USA |